medical glp-1 weight loss sublingual Treatment GLP-TRIM - A Natural GLP-1

The use of SMG is essentially indicated for the control of DM2 (Ozempic ) and obesity or overweight associated with comorbidities (Wegovy )

After a median follow-up of 33 months (range 2436 months), mean weight loss and percentage of weight loss at 2 years were 32.5 kg (24.938.3 kg) and 63.2% (range 50.586.2%), respectively, without major postoperative complications

Clinical studies show patients typically regain a substantial portion of lost weight without continued treatment or alternative weight management strategies

This was solved once Collip found a way to remove contaminants from the extract

Neurotherapeutics 15 (2), 391401

Novel, in-vivo and in vitro data suggest that exenatide, a GLP-1 receptor agonist, may represent an ideal therapy for IIH through rapid reduction of CSF secretion at the choroid plexus, lowering ICP in addition to its weight loss properties